ABVC BioPharma Enters Into $3.0 Million Clinical Services Contract with NeuCen BioMed
03. Mai 2022 08:30 ET
|
ABVC BioPharma, Inc.
FREMONT, CA, May 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...